1492 Capital Management’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-6,367
| Closed | -$767K | – | 99 |
|
|
2019
Q4 | $767K | Sell |
6,367
-779
| -11% | -$93.8K | 0.68% | 42 |
|
|
2019
Q3 | $1.3M | Sell |
7,146
-5,870
| -45% | -$1.07M | 1.26% | 28 |
|
|
2019
Q2 | $1.69M | Sell |
13,016
-68
| -0.5% | -$8.84K | 1.58% | 21 |
|
|
2019
Q1 | $3.19M | Sell |
13,084
-913
| -7% | -$222K | 2.7% | 10 |
|
|
2018
Q4 | $2.67M | Buy |
13,997
+6,636
| +90% | +$1.26M | 2.39% | 14 |
|
|
2018
Q3 | $2.41M | Sell |
7,361
-29
| -0.4% | -$9.51K | 1.57% | 24 |
|
|
2018
Q2 | $2.31M | Sell |
7,390
-55
| -0.7% | -$17.2K | 1.65% | 24 |
|
|
2018
Q1 | $1.81M | Sell |
7,445
-306
| -4% | -$74.5K | 1.39% | 27 |
|
|
2017
Q4 | $2.34M | Sell |
7,751
-63
| -0.8% | -$19K | 1.83% | 21 |
|
|
2017
Q3 | $2.07M | Buy |
7,814
+3,622
| +86% | +$958K | 1.83% | 20 |
|
|
2017
Q2 | $1.11M | Sell |
4,192
-258
| -6% | -$68K | 0.97% | 34 |
|
|
2017
Q1 | $1.6M | Sell |
4,450
-947
| -18% | -$341K | 1.25% | 28 |
|
|
2016
Q4 | $1.56M | Buy |
5,397
+4,692
| +666% | +$1.35M | 1.2% | 30 |
|
|
2016
Q3 | $240K | Sell |
705
-45
| -6% | -$15.3K | 0.2% | 84 |
|
|
2016
Q2 | $319K | Sell |
750
-73
| -9% | -$31K | 0.29% | 72 |
|
|
2016
Q1 | $263K | Buy |
823
+186
| +29% | +$59.4K | 0.22% | 82 |
|
|
2015
Q4 | $330K | Buy |
+637
| New | +$330K | 0.24% | 79 |
|